| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Trescowthick Research Laboratories, Peter MacCallum Cancer Centre, East Melbourne, Melbourne, Victoria, Australia and 2 Department of Medicine, University of Melbourne, St. Vincent's Hospital, Fitzroy, Victoria, Australia
Requests for reprints: Robin L. Anderson, Trescowthick Research Laboratories, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, Melbourne, Victoria, Australia 8006. Phone: 61-3-9656-1285; Fax: 61-3-9656-1411. E-mail: robin.anderson{at}petermac.org
A clinically relevant model of spontaneous breast cancer metastasis to multiple sites, including bone, was characterized and used to identify genes involved in metastatic progression. The metastatic potential of several genetically related tumor lines was assayed using a novel real-time quantitative RT-PCR assay of tumor burden. Based on this assay, the tumor lines were categorized as nonmetastatic (67NR), weakly metastatic to lymph node (168FARN) or lung (66cl4), or highly metastatic to lymph node, lung, and bone (4T1.2 and 4T1.13). In vitro assays that mimic stages of metastasis showed that highly metastatic tumors lines were more adhesive, invasive, and migratory than the less metastatic lines. To identify metastasis-related genes in this model, each metastatic tumor was array profiled against the nonmetastatic 67NR using 15,000 mouse cDNA arrays. A significant proportion of genes relating to the extracellular matrix had elevated expression in highly metastatic tumors. The role of one of these genes, POEM, was further investigated in the model. In situ hybridization showed that POEM expression was specific to the tumor epithelium of highly metastatic tumors. Decreased POEM expression in 4T1.2 tumors significantly inhibited spontaneous metastasis to the lung, bone, and kidney. Taken together, our data support a role for the extracellular matrix in metastatic progression and describe, for the first time, a role for POEM in this process.
Key Words: Breast cancer • spontaneous metastasis • mouse model • microarray • POEM
This article has been cited by other articles:
|
|
 |
|
  C. N. Perera, H. S. Spalding, S. I. Mohammed, and I. G. Camarillo Identification of Proteins Secreted from Leptin Stimulated MCF-7 Breast Cancer Cells: A Dual Proteomic Approach Experimental Biology and Medicine, June 1, 2008; 233(6): 708 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A.N. Rose, F. Pepin, C. Russo, J. E. Abou Khalil, M. Hallett, and P. M. Siegel Osteoactivin Promotes Breast Cancer Metastasis to Bone Mol. Cancer Res., October 1, 2007; 5(10): 1001 - 1014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-P. Levesque, I. G. Winkler, J. Hendy, B. Williams, F. Helwani, V. Barbier, B. Nowlan, and S. K. Nilsson Hematopoietic Progenitor Cell Mobilization Results in Hypoxia with Increased Hypoxia-Inducible Transcription Factor-1{alpha} and Vascular Endothelial Growth Factor A in Bone Marrow Stem Cells, August 1, 2007; 25(8): 1954 - 1965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Chia, N. Kusuma, R. Anderson, B. Parker, B. Bidwell, L. Zamurs, E. Nice, and N. Pouliot Evidence for a Role of Tumor-Derived Laminin-511 in the Metastatic Progression of Breast Cancer Am. J. Pathol., June 1, 2007; 170(6): 2135 - 2148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Gozgit, B. T. Pentecost, S. A. Marconi, C. N. Otis, C. Wu, and K. F. Arcaro Use of an Aggressive MCF-7 Cell Line Variant, TMX2-28, to Study Cell Invasion in Breast Cancer Mol. Cancer Res., December 1, 2006; 4(12): 905 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. W. Rahman, F. H. Sarkar, S. Banerjee, Z. Wang, D. J. Liao, X. Hong, and N. H. Sarkar Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model. Mol. Cancer Ther., November 1, 2006; 5(11): 2747 - 2756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R.E. Rees, B. A. Onwuegbusi, V. E. Save, D. Alderson, and R. C. Fitzgerald In vivo and In vitro Evidence for Transforming Growth Factor-{beta}1-Mediated Epithelial to Mesenchymal Transition in Esophageal Adenocarcinoma Cancer Res., October 1, 2006; 66(19): 9583 - 9590. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Beisner, M. B. Buck, P. Fritz, J. Dippon, M. Schwab, H. Brauch, G. Zugmaier, K. Pfizenmaier, and C. Knabbe A Novel Functional Polymorphism in the Transforming Growth Factor-{beta}2 Gene Promoter and Tumor Progression in Breast Cancer. Cancer Res., August 1, 2006; 66(15): 7554 - 7561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Castoldi, S. Schmidt, V. Benes, M. Noerholm, A. E. Kulozik, M. W. Hentze, and M. U. Muckenthaler A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA) RNA, May 1, 2006; 12(5): 913 - 920. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
